[Place of cancer among the risk factors in venous thromboembolism].

Abstract : There is a strong association between cancer and venous thromboembolism (VTE). Cancer patients have a seven-fold higher risk of developing VTE as compared with noncancer patients. In the year following the diagnosis of cancer, 1.6% of patients will develop a VTE event. VTE is one of the main cause of death in cancer patients, accounting for about 15% of deaths. On the other hand, cancer patients represent 15 to 20% of all VTE cases. Beyond classical risk factors for VTE, specific risk factors are associated with VTE in cancer patients: tumor site, stage, histological type, treatment, duration of the disease. VTE occurrence is associated with a poorer outcome in cancer patients: a reduced survival is observed in cancer patients with VTE as compared to non-VTE cancer patients. This impact of VTE on prognosis varies according to cancer characteristics. Conversely, evolution of VTE is different in cancer patients, with a higher short-term risk of mortality and a higher risk of recurrences, including on anticoagulant treatment, also modulated by cancer characteristics.
Type de document :
Article dans une revue
Pathologie Biologie, Elsevier Masson, 2008, 56 (4), pp.178-83. 〈10.1016/j.patbio.2007.12.008〉
Liste complète des métadonnées

Contributeur : Ghislaine Calvez <>
Soumis le : vendredi 30 mars 2012 - 16:55:04
Dernière modification le : lundi 28 mai 2018 - 18:06:02




Renaud Descourt, Marc Righini, Marc Carrier, Grégoire Le Gal. [Place of cancer among the risk factors in venous thromboembolism].. Pathologie Biologie, Elsevier Masson, 2008, 56 (4), pp.178-83. 〈10.1016/j.patbio.2007.12.008〉. 〈hal-00684166〉



Consultations de la notice